Anika Therapeutics (ANIK) P/FCF US GAAP (year values) |
|||||||||
| 2023 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -46.0 | -46.0 | -104.0 | 31.6 | 192.4 | ||||
| Changes by years, y/y, % | -100% | 0% | +126% | -130% | -10.9% | ||||
Anika Therapeutics. P/FCF
Anika Therapeutics. P/FCF, changes, %
Anika Therapeutics (ANIK) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | -54.4 | -133.9 | 209.2 | 31.4 | 188.8 | 192.4 | ||
| Changes by years, y/y, % | -40% | -140% | -181% | -138% | -447% | |||
| Changes by quarters, q/q, % | -34% | +146% | -256% | -85% | +501% | |||